Hypoparathyroidism Associated with the DNA Variants in Non-Coding Sequence Region of Calcium-Sensing Receptor

Qiang Zhang , Li-Jie Zhang , Sha-Sha Yuan , Xiao-Jiang Quan , Bao-Yu Zhang , Dong Zhao
{"title":"Hypoparathyroidism Associated with the DNA Variants in Non-Coding Sequence Region of Calcium-Sensing Receptor","authors":"Qiang Zhang ,&nbsp;Li-Jie Zhang ,&nbsp;Sha-Sha Yuan ,&nbsp;Xiao-Jiang Quan ,&nbsp;Bao-Yu Zhang ,&nbsp;Dong Zhao","doi":"10.1016/j.endmts.2021.100106","DOIUrl":null,"url":null,"abstract":"<div><p>A stable narrow range of extracellular calcium concentration in the blood is essential for life. The calcium-sensing receptor (CaSR), a member of the G protein-coupled receptors family, is required to adjust the set point of blood extracellular calcium concentration, thus regulate parathyroid hormone (PTH) secretion and renal calcium excretion. Loss or gain function of CaSR mutations may result in either hyper- or hypocalcaemia. The CaSR activating mutations increase its sensitivity to extracellular ionized calcium (Ca<sup>2+</sup>). As consequence, PTH synthesis and secretion are suppressed continuously at normal ionized calcium concentrations. Patients display hypocalcaemia, hyperphosphatemia and lower levels of PTH. Urinary calcium excretion is increased due to the decreased circulating inappropriately PTH level and the activation of the renal tubular CaSR. Therefore, CaSR becomes a good potential clinical therapeutic target for hypoparathyroidism treatment. In order to define new drugs and improve medical management of hypoparathyroidism patients, this study attempts to identify new CaSR variants and analyse in detail the functional change of these CaSR variants, thus better understand the molecular mechanism involved. The study is based on collected hypoparathyroidism patients in our clinical site. In the study we enrolled in 10 patients, obtained all their clinical results and DNA results from seven patients. Our results indicated that the effect of serum intact PTH level correlated to change of serum Ca<sup>2+</sup> and phosphate level. The CaSR carrying newly identified DNA variants displayed strong phosphorylation of phospholipase C and mitogen-activated protein kinases. Although the size of clinical cases need to be accumulated, current cases have showed a tendency that the identified multiple DNA variants in CaSR gene revealed an effect on the diagnostic criterion of the hypocalcaemic syndrome. It is undeniable that our research has certain limitations. So far, we tested several DNA variants at the same time, further functional examination for individual DNA variant would largely help to be better understand the mechanisms of CaSR regulation on extracellular calcium concentration.</p></div>","PeriodicalId":34427,"journal":{"name":"Endocrine and Metabolic Science","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endmts.2021.100106","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine and Metabolic Science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666396121000297","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

A stable narrow range of extracellular calcium concentration in the blood is essential for life. The calcium-sensing receptor (CaSR), a member of the G protein-coupled receptors family, is required to adjust the set point of blood extracellular calcium concentration, thus regulate parathyroid hormone (PTH) secretion and renal calcium excretion. Loss or gain function of CaSR mutations may result in either hyper- or hypocalcaemia. The CaSR activating mutations increase its sensitivity to extracellular ionized calcium (Ca2+). As consequence, PTH synthesis and secretion are suppressed continuously at normal ionized calcium concentrations. Patients display hypocalcaemia, hyperphosphatemia and lower levels of PTH. Urinary calcium excretion is increased due to the decreased circulating inappropriately PTH level and the activation of the renal tubular CaSR. Therefore, CaSR becomes a good potential clinical therapeutic target for hypoparathyroidism treatment. In order to define new drugs and improve medical management of hypoparathyroidism patients, this study attempts to identify new CaSR variants and analyse in detail the functional change of these CaSR variants, thus better understand the molecular mechanism involved. The study is based on collected hypoparathyroidism patients in our clinical site. In the study we enrolled in 10 patients, obtained all their clinical results and DNA results from seven patients. Our results indicated that the effect of serum intact PTH level correlated to change of serum Ca2+ and phosphate level. The CaSR carrying newly identified DNA variants displayed strong phosphorylation of phospholipase C and mitogen-activated protein kinases. Although the size of clinical cases need to be accumulated, current cases have showed a tendency that the identified multiple DNA variants in CaSR gene revealed an effect on the diagnostic criterion of the hypocalcaemic syndrome. It is undeniable that our research has certain limitations. So far, we tested several DNA variants at the same time, further functional examination for individual DNA variant would largely help to be better understand the mechanisms of CaSR regulation on extracellular calcium concentration.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲状旁腺功能减退与钙敏感受体非编码序列区DNA变异相关
血液中细胞外钙浓度稳定的窄范围是维持生命所必需的。钙敏感受体(calcium-sensing receptor, CaSR)是G蛋白偶联受体家族中的一员,需要调节血液细胞外钙浓度的设定点,从而调节甲状旁腺激素(parathyroid hormone, PTH)的分泌和肾脏钙的排泄。CaSR突变的丧失或获得功能可能导致高或低钙血症。CaSR激活突变增加了其对细胞外离子钙(Ca2+)的敏感性。因此,在正常离子钙浓度下,甲状旁腺激素的合成和分泌持续受到抑制。患者表现为低钙血症、高磷血症和较低水平的甲状旁腺激素。尿钙排泄增加是由于循环中不适当的甲状旁腺激素水平降低和肾小管CaSR的激活。因此,CaSR成为治疗甲状旁腺功能减退症的潜在临床治疗靶点。为了确定新的药物,改善甲状旁腺功能减退患者的医疗管理,本研究试图鉴定新的CaSR变异,并详细分析这些CaSR变异的功能变化,从而更好地了解其分子机制。这项研究是基于收集的甲状旁腺功能减退症患者在我们的临床现场。在这项研究中,我们招募了10名患者,获得了其中7名患者的所有临床结果和DNA结果。我们的结果表明,血清完整PTH水平的影响与血清Ca2+和磷酸盐水平的变化有关。携带新鉴定的DNA变体的CaSR显示出磷脂酶C和丝裂原活化蛋白激酶的强烈磷酸化。虽然临床病例的规模有待积累,但目前的病例已经显示出一种趋势,即发现的CaSR基因的多个DNA变异对低钙血症综合征的诊断标准有影响。不可否认,我们的研究有一定的局限性。到目前为止,我们同时测试了几种DNA变体,进一步对单个DNA变体进行功能检查将有助于更好地理解CaSR调控细胞外钙浓度的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Endocrine and Metabolic Science
Endocrine and Metabolic Science Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.80
自引率
0.00%
发文量
4
审稿时长
84 days
期刊最新文献
Long-term diabetic hyperglycaemia modifies social behaviour in rats Platelet activation and inflammation in transgender women using hormone therapy Prevalence of thyroid dysfunction among pregnant women in the horn of Africa: A systematic review and Meta-analysis Increase of serum vitamin D levels in the COVID-19 pandemic: Report of a Mexican reference clinical laboratory Hypoalbuminemia on admission in diabetic patients correlates with severity of illness in COVID-19: A retrospective clinical study and literature review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1